Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Lupus

Review

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus

Online download statistics by month:

Online download statistics by month: July 2020 to March 2023

	Abstract	Full	Pdf
Jul 2020	235	243	68
Aug 2020	130	120	120
Sep 2020	92	82	51
Oct 2020	87	80	30
Nov 2020	47	45	26
Dec 2020	56	54	24
Jan 2021	97	95	30
Feb 2021	106	106	32
Mar 2021	95	93	41
Apr 2021	103	101	40
May 2021	86	86	29
Jun 2021	68	65	32
Jul 2021	48	47	18
Aug 2021	74	72	41
Sep 2021	45	45	31
Oct 2021	65	64	51
Nov 2021	63	61	36
Dec 2021	72	72	33
Jan 2022	44	42	15
Feb 2022	67	67	34
Mar 2022	92	91	43
Apr 2022	71	67	25
May 2022	69	67	31
Jun 2022	79	81	33
Jul 2022	44	45	24
Aug 2022	67	64	13
Sep 2022	85	88	38
Oct 2022	104	103	46
Nov 2022	73	70	36
Dec 2022	46	43	18
Jan 2023	70	74	39
Feb 2023	67	68	26
Total	2547	2501	1154